1. A multicentre, multinational, randomized, placebo‐controlled, double‐blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15‐0444) in patients with type 2 diabetes. Issue 5 (17th December 2012) Authors: Yang, S. J.; Min, K. W.; Gupta, S. K.; Park, J. Y.; Shivane, V. K.; Pitale, S. U.; Agarwal, P. K.; Sosale, A.; Gandhi, P.; Dharmalingam, M.; Mohan, V.; Mahesh, U.; Kim, D. M.; Kim, Y. S.; Kim, J. A.; Kim, P. K.; Baik, S. H. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 5(2013:May) Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗